Results at 2 years of a phase IIb extension study of the exon-skipping drug eteplirsen in patients with DMD

被引：1
|
作者：
Mendell, J. R. [1 ]
Rodino-Klapac, L. [1 ]
Sahenk, Z. [1 ]
Roush, K. [1 ]
Bird, L. [1 ]
Lowes, L. P. [1 ]
Alfano, L. [1 ]
Gomez, A. M. [1 ]
Lewis, S. [1 ]
Malik, V. [1 ]
Shontz, K. [1 ]
Flanigan, K. M. [1 ]
Kean, J. R. [1 ]
Allen, H. D. [1 ]
Shilling, C. [1 ]
Sazani, P. [2 ]
Saoud, J. [2 ]
Kaye, E. M. [2 ]
机构：
[1] Nationwide Childrens Hosp, Columbus, OH USA
[2] Sarepta Therapeut, Cambridge, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2013年 / 23卷 / 9-10期
关键词：
D O I：
10.1016/j.nmd.2013.06.581
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：804 / 805
页数：2
相关论文
共 50 条
  • [41] Long-term MRI outcomes from patients treated with teriflunomide: results from a phase 2 extension study
    Li, D. B. K.
    Traboulsee, A. L.
    Truffinet, P.
    Dukovic, D.
    O'Connor, P. W.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 102 - 103
  • [42] RESULTS OF A PHASE IIB STUDY WITH TRABEDERSEN (AP 12009) IN RECURRENT OR REFRACTORY HIGH-GRADE GLIOMA PATIENTS
    Bogdahn, Ulrich
    Rappaport, Z. H.
    Olyusin, V.
    Parfenov, V.
    Mahapatra, A. K.
    Balasubramaniam, A.
    Vankataramana, N. K.
    Stockhammer, G.
    Heinrichs, H.
    Schlingensiepen, K. -H.
    NEURO-ONCOLOGY, 2009, 11 (06) : 907 - 908
  • [43] Results of a phase Iib active-controlled study with AP 12009 for patients with recurrent or refractory anaplastic astrocytoma
    Bogdahn, U.
    Mahapatra, A. K.
    Olyushin, V.
    Parfenov, V.
    Stockhammer, G.
    Ludwig, S.
    Wuerth, G.
    Heinrichs, H.
    Schlingensiepen, K. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Results of the cardiological rehabilitation (phase 2) in patients of more than 75 years
    Schutz, J
    HERZ KREISLAUF, 1998, 30 (10): : 345 - 351
  • [45] Minimal Spinal Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis over 2 Years of Bimekizumab Treatment: Results from a Phase 3 Open-Label Extension Study
    Baraliakos, Xenofon
    Ramiro, Sofia
    Maksymowych, Walter
    Ostergaard, Mikkel
    Massow, Ute
    Vaux, Thomas
    Prajapati, Chetan
    Marten, Alexander
    de Peyrecave, Natasha
    Poddubnyy, Denis
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3591 - 3593
  • [46] Design of a Phase 2/3 randomized controlled trial of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy amenable to exon 51 skipping
    Wagner, K.
    Cripe, L.
    Eagle, M.
    Muntoni, F.
    Niks, E.
    Phan, H.
    Straub, V.
    Hu, X.
    Antonijevic, I.
    Berry, S.
    Quintana, M.
    Lake, S.
    Panzara, M.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S176 - S177
  • [47] Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
    Cirak, Sebahattin
    Arechavala-Gomeza, Virginia
    Guglieri, Michela
    Feng, Lucy
    Torelli, Silvia
    Anthony, Karen
    Abbs, Stephen
    Garralda, Maria Elena
    Bourke, John
    Wells, Dominic J.
    Dickson, George
    Wood, Matthew J. A.
    Wilton, Steve D.
    Straub, Volker
    Kole, Ryszard
    Shrewsbury, Stephen B.
    Sewry, Caroline
    Morgan, Jennifer E.
    Bushby, Kate
    Muntoni, Francesco
    LANCET, 2011, 378 (9791): : 595 - 605
  • [48] Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results Through 2 Years of the GO-FORWARD Study Extension
    Keystone, Edward C.
    Genovese, Mark C.
    Hall, Stephen
    Miranda, Pedro C.
    Bae, Sang-Cheol
    Palmer, William
    Wu, Zhong
    Xu, Stephen
    Hsia, Elizabeth C.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) : 1097 - 1103
  • [49] Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
    Baraliakos, Xenofon
    Deodhar, Atul
    Dougados, Maxime
    Gensler, Lianne S.
    Molto, Anna
    Ramiro, Sofia
    Kivitz, Alan J.
    Poddubnyy, Denis
    Oortgiesen, Marga
    Vaux, Thomas
    Fleurinck, Carmen
    Shepherd-Smith, Julie
    de la Loge, Christine
    de Peyrecave, Natasha
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (12) : 1943 - 1958
  • [50] Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
    Coates, Laura C.
    McInnes, Iain B.
    Merola, Joseph F.
    Warren, Richard B.
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Gossec, Laure
    Assudani, Deepak
    Bajracharya, Rajan
    Coarse, Jason
    Ink, Barbara
    Ritchlin, Christopher T.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (12) : 1959 - 1970
12345